TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2134265-2012-08216
- Event Type
- Injury
- Date Received
- December 20, 2012
- Date of Event
- October 3, 2012
- Report Date
- December 4, 2012
- Product Code
- NIQ
- PMA / PMN Number
- P030025
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE IS A COMBINATION PRODUCT. (B)(6). DEVICE EVALUATED BY MANUFACTURER: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
(B)(4) STUDY. IT WAS REPORTED THAT POST CORONARY STENTING TREATMENT PROCEDURE, SILENT ISCHEMIA AND IN-STENT RESTENOSIS OCCURRED. IN (B)(6) 2008, A TAXUS EXPRESS 2 STENT WAS IMPLANTED IN A LESION LOCATED IN THE DISTAL CIRCUMFLEX (CX). IN (B)(6) 2012, CORONARY ANGIOGRAPHY REVEALED 75% RESTENOSIS IN THE DISTAL CX. THE RESTENOSIS WAS 30 MM LONG WITH A DIAMETER OF 2.75 MM. THE SUBJECT EXPERIENCED SILENT ISCHEMIA AND THE LESION WAS TREATED WITH DILATATION USING A NON-BSC BALLOON CATHETER AND TWO NON-BSC STENTS (2.5 X 18 AND 2.75 X 14) WERE IMPLANTED. IN ADDITION, 75% STENOSIS WAS NOTED IN THE LEFT ATRIOVENTRICULAR ARTERY. THE STENOSIS WAS 13 MM LONG WITH A DIAMETER OF 2.5MM AND WAS TREATED WITH DILATATION USING AN UNKNOWN BALLOON CATHETER AND THE PLACEMENT OF A 2.5 X 14 NON-BSC STENT. IT WAS ALSO REPORTED THAT AN ARCTATION OCCURRED. ANTIPLATELET MEDICATION INCLUDED HEPARIN7000 U (B)(6) 2012, HEPARIN 5000U (B)(6) 2012, PLAVIX 75MG, AND BAYASPIRIN 100MG.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM | CORONARY DRUG-ELUTING STENT | NIQ | UNK432 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |